Clinical Trials

Phase 1/2 Active not recruiting

Breast Adenocarcinoma

NCT02734004 2026-04-20

MEDIOLA

264 enrolled 32 charts

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT03280563 2025-11-10

MORPHEUS HR+BC

Phase 1/2 Completed

144 enrolled 25 charts

Breast Neoplasms

NCT00861705 2025-09-30

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

454 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

394 enrolled 11 charts

Breast Neoplasms

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Phase 3 Terminated

96 enrolled 16 charts

Breast Neoplasms

NCT03387085 2024-08-09

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

Phase 1/2 Terminated

9 enrolled 18 charts

Triple Negative Breast Neoplasms

NCT00618657 2024-02-28

Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting

127 enrolled 12 charts

Breast Neoplasms

NCT02456857 2024-02-13

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

17 enrolled 8 charts

Triple Negative Breast Neoplasms

NCT00679029 2023-12-11

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

15 enrolled 9 charts

Breast Neoplasms

NCT00545077 2023-03-31

Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

380 enrolled 21 charts

Breast Neoplasms

NCT00608972 2023-02-08

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

31 enrolled 11 charts

Breast Neoplasms

NCT00530868 2022-10-21

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

75 enrolled 9 charts

Breast Neoplasms

NCT00785291 2022-10-10

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

799 enrolled 18 charts

Breast Neoplasms

NCT00925652 2022-01-19

ABCDE

55 enrolled 11 charts

Breast Neoplasms

NCT00405938 2021-11-18

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

79 enrolled 7 charts

Breast Neoplasms

NCT00444535 2021-10-25

Lapatinib and Bevacizumab for Metastatic Breast Cancer

52 enrolled 13 charts

Breast Neoplasms, Osteitis Deformans

NCT00464646 2021-10-25

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

105 enrolled 17 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00580333 2021-05-26

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

51 enrolled 7 charts

Breast Neoplasms

NCT00546156 2021-05-18

Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer

104 enrolled 7 charts

Breast Neoplasms

NCT00723125 2021-04-29

Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer

60 enrolled 7 charts

Breast Neoplasms

NCT00365417 2021-04-13

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

45 enrolled 15 charts

Breast Neoplasms

NCT00461773 2021-03-16

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

5 enrolled 7 charts

Breast Neoplasms

NCT00536939 2020-09-24

Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

2 enrolled 5 charts

Breast Neoplasms

NCT00217672 2020-08-05

Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer

76 enrolled 11 charts

BreastGastrointestinalThoracic

Breast Neoplasms

NCT01803282 2020-06-02

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Phase 1 Completed

236 enrolled 21 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02613208 2020-02-17

Argo

Completed

111 enrolled 14 charts

Breast Neoplasms

NCT00600340 2019-12-30

TURANDOT

564 enrolled 72 charts

Breast Neoplasms

NCT00394082 2019-11-25

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

50 enrolled 17 charts

Breast Neoplasms

NCT00394251 2019-11-25

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

197 enrolled 23 charts

Breast Neoplasms

NCT00281528 2019-11-22

Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer

208 enrolled 23 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00240071 2019-10-30

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

30 enrolled 7 charts

Breast Neoplasms

NCT00462865 2019-04-09

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

18 enrolled 8 charts

Breast Neoplasms

NCT01959490 2019-03-05

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

16 enrolled 8 charts

Breast Neoplasms

NCT00254592 2019-02-28

Neoadjuvant Treatment of Breast Cancer

43 enrolled 7 charts

Breast Neoplasms

NCT00403130 2019-02-20

Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer

31 enrolled 11 charts

Breast Neoplasms

NCT01663727 2019-01-22

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

481 enrolled 22 charts

Breast Neoplasms

NCT01004172 2018-12-14

Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases

38 enrolled 12 charts

Breast Neoplasms

NCT00733408 2018-12-04

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

59 enrolled 14 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00428922 2018-08-09

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

26 enrolled 5 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00675259 2018-07-24

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

33 enrolled 10 charts

Breast Neoplasms

NCT00423917 2018-05-08

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

36 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00559845 2018-04-09

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

56 enrolled 10 charts

Breast Neoplasms

NCT01094184 2018-03-22

BATMAN

Phase 4 Completed

49 enrolled 120 charts

Breast Neoplasms

NCT00632541 2018-02-14

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

18 enrolled 11 charts

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast Neoplasms

NCT00654836 2017-09-14

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

32 enrolled 16 charts

Breast Neoplasms

NCT00054132 2017-07-24

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer

38 enrolled 10 charts

Breast Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

215 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00503906 2017-05-12

Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer

30 enrolled 10 charts